Volume 14, Issue 3 (May 2012) 14, 347–348; 10.1038/aja.2012.34

Helping to address the over treatment of prostate cancer: tools to differentiate lethal and non-lethal phenotype in prostate cancer

Robert H Getzenberg¹ and H Ballentine Carter²

1 Department of Urology, The Brady Urological Institute, Johns Hopkins Hospital , Baltimore, MD 21287, USA (rgetzen1@jhmi.edu)
2 Department of Urology, The Johns Hopkins University School of Medicine and The James Buchanan Brady Urological Institute, The Johns Hopkins Hospital , Baltimore, MD 21287, USA (carter.ballentine3@gmail.com)